Surgery Partners (SGRY) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Jefferies Cuts Price Target on Surgery Partners, Inc. (SGRY) to $24 Following 3Q
November 10, 2016 10:19 AM ESTJefferies maintained a Buy rating on Surgery Partners, Inc. (NASDAQ: SGRY), and cut the price target to $24.00 (from $27.00), following the company's 3Q earnings report. SGRY put up strong SS rev growth of +10.3% in Q3, which highlights the company's ability to continue driving consistent, double-digit... More
